نتایج جستجو برای: brca1 و brca2

تعداد نتایج: 770130  

Journal: :European journal of cancer 2000
H Ozdag M Tez I Sayek M Müslümanoglu O Tarcan F Içli M Oztürk T Ozçelik

Germ line BRCA1 and/or BRCA2 mutations were screened in 50 Turkish breast and/or ovarian cancer patients composed of hereditary, familial, early onset and male cancer groups. Genomic DNA samples were tested by heteroduplex analysis and DNA sequencing. Two truncating BRCA2 mutations, one novel (6880 insG) and one previously reported (3034 delAAAC), were found in two out of six (33%) hereditary b...

Journal: :Human molecular genetics 2015
Johnny Loke Alexander Pearlman Kinnari Upadhyay Lydia Tesfa Yongzhao Shao Harry Ostrer

Heritable mutations in the BRCA1 and BRCA2 and other genes in the DNA double-strand break (DSB) repair pathway disrupt binding of the encoded proteins, transport into the nucleus and initiation of homologous recombination, thereby increasing cancer risk [Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T. and Livingston, D.M. (1997) Association of BRCA1 with Rad51 in ...

Recent advances in DNA sequencing techniques have led to an increase in the identification of single nucleotide polymorphisms (SNPs) in BRCA1 and BRCA2 genes, but no further information regarding the deleterious probability of many of them is available (Variants of Unknown Significance/VUS). As a result, in the current study, different sequence- and structure-based computation...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011
Amanda B Spurdle Louise Marquart Lesley McGuffog Sue Healey Olga Sinilnikova Fei Wan Xiaoqing Chen Jonathan Beesley Christian F Singer Anne-Catharine Dressler Daphne Gschwantler-Kaulich Joanne L Blum Nadine Tung Jeff Weitzel Henry Lynch Judy Garber Douglas F Easton Susan Peock Margaret Cook Clare T Oliver Debra Frost Don Conroy D Gareth Evans Fiona Lalloo Ros Eeles Louise Izatt Rosemarie Davidson Carol Chu Diana Eccles Christina G Selkirk Mary Daly Claudine Isaacs Dominique Stoppa-Lyonnet Olga M Sinilnikova Bruno Buecher Muriel Belotti Sylvie Mazoyer Laure Barjhoux Carole Verny-Pierre Christine Lasset Hélène Dreyfus Pascal Pujol Marie-Agnès Collonge-Rame Matti A Rookus Senno Verhoef Mieke Kriege Nicoline Hoogerbrugge Margreet G E M Ausems Theo A van Os Juul Wijnen Peter Devilee Hanne E J Meijers-Heijboer Marinus J Blok Tuomas Heikkinen Heli Nevanlinna Anna Jakubowska Jan Lubinski Tomasz Huzarski Tomasz Byrski Francine Durocher Fergus J Couch Noralane M Lindor Xianshu Wang Mads Thomassen Susan Domchek Kate Nathanson Ma Caligo Helena Jernström Annelie Liljegren Hans Ehrencrona Per Karlsson Patricia A Ganz Olufunmilayo I Olopade Gail Tomlinson Susan Neuhausen Antonis C Antoniou Georgia Chenevix-Trench Timothy R Rebbeck

BACKGROUND Inherited BRCA1 and BRCA2 (BRCA1/2) mutations confer elevated breast cancer risk. Knowledge of factors that can improve breast cancer risk assessment in BRCA1/2 mutation carriers may improve personalized cancer prevention strategies. METHODS A cohort of 5,546 BRCA1 and 2,865 BRCA2 mutation carriers was used to evaluate risk of breast cancer associated with BARD1 Cys557Ser. In a sec...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2014
Elif Erturk Gulsah Cecener Volkan Polatkan Sehsuvar Gokgoz Unal Egeli Berrin Tunca Gulcin Tezcan Elif Demirdogen Secil Ak Ismet Tasdelen

Although genetic markers identifying women at an increased risk of developing breast cancer exist, the majority of inherited risk factors remain elusive. Mutations in the BRCA1/BRCA2 gene confer a substantial increase in breast cancer risk, yet routine clinical genetic screening is limited to the coding regions and intron- exon boundaries, precluding the identification of mutations in noncoding...

Journal: :Journal of medical genetics 1997
A M Garvin M Attenhofer-Haner R J Scott

Eighty-six women fulfilling specific selection criteria were studied for germline mutations in two breast cancer susceptibility genes, BRCA1 and BRCA2, using the protein truncation test (PTT). Nine germline mutations were identified, six in BRCA1 and three in BRCA2. Of the six BRCA1 mutations, three have previously been described and three are new, and for BRCA2, one is a new mutation and the o...

2015
GAETANA GAMBINO MARIELLA TANCREDI ELISABETTA FALASCHI PAOLO ARETINI MARIA ADELAIDE CALIGO

The study of BRCA1 and BRCA2 genes and their alterations has been essential to the understanding of the development of familial breast and ovarian cancers. Many of the variants identified have an unknown pathogenic significance. These include variants which determine alternative mRNA splicing, identified in the intronic regions and those are capable of destroying the splicing ability. The aim o...

2010

• BRCA1 and BRCA2 are human genes that belong to a class of genes known as tumor suppressors. Mutation of these genes has been linked to hereditary breast and ovarian cancer (see Question 1). • A woman's risk of developing breast and/or ovarian cancer is greatly increased if she inherits a deleterious (harmful) BRCA1 or BRCA2 mutation. Men with these mutations also have an increased risk of bre...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2006
Sharon Simchoni Eitan Friedman Bella Kaufman Ruth Gershoni-Baruch Avi Orr-Urtreger Inbal Kedar-Barnes Ronit Shiri-Sverdlov Efrat Dagan Sigal Tsabari Mordechai Shohat Raphael Catane Mary-Claire King Amnon Lahad Ephrat Levy-Lahad

Inherited mutations in BRCA1 and BRCA2 lead to significantly increased risks of breast and ovarian cancer. We used epidemiologic methods to evaluate the relative risks of breast cancer vs. ovarian cancer among women of Ashkenazi Jewish ancestry with inherited mutations in BRCA1 or BRCA2. The cancer of a family's index case (i.e., breast cancer vs. ovarian cancer) was significantly associated wi...

Journal: :Journal of medical genetics 2005
D G R Evans F Lalloo A Wallace N Rahman

We recently published a new scoring system to estimate the chance of identifying mutations in the BRCA1 and BRCA2 genes (table 1). A potential criticism of the original paper was that not all cases were fully screened for mutations in both BRCA1 and BRCA2. We have now extended our analyses to address this. In total, we have screened 921 samples from familial breast cancer pedigrees from the Man...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید